Home > News/Research Updates > 2009 Archives
 News/Research Archives - 2009
 All facts and opinions are those of the sources cited, unless otherwise specified. News/Research items have been edited for length and/or modified for clarity without altering essential data as originally published. Pain Treatment Topics and its associates do not endorse any medications, products, services, or treatments mentioned in any of these News/Research Update items or the referenced sources. Also see the Disclaimer at the end of these Updates.
Click on links below to view Update items of interest.
Don't miss out... register here for e-Notifications of when the next News/Research UPDATES are posted.
News/Research UPDATES Issues - 2009
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
December 2009
Want Less Pain? Rip Off Adhesive Bandage Quickly 12/19
Texting A Real Pain in the Neck (and Shoulders) 12/18
Pain Relieving Coxibs Counter Aspirin’s Benefits 12/17
Racial, Ethnic Disparities in Pain Care Examined 12/11
Canadian Study Distorts Rx-Opioid-Related Deaths 12/10
Opioid REMS: When Elephants Prance, Ants Take a Pounding 12/6
Powers of Placebo in Pain Management Revisited 12/6
Intranasal Naloxone for Overcoming Opioid Overdose 12/4
Migraine Relief: Looking Beyond Medications 12/1
Aches, Pains in Elderly Increase Hazardous Falls 12/1
December 2009 – Pain Product Announcements & Warnings 12/1
Generic oral transmucosal fentanyl citrate (OTFC) approval, capsaicin skin patch (Qutenza) approval, diclofenac sodium topical (Pennsaid) approved for knee OA, generic tramadol hydrochloride approval.
<Back to Top>
November 2009
Opioid Rotation: Benefits, Challenges, Hazards 11/21
Fatigue a Good Indicator of RA Treatment Success 11/20
Depressed Patients Receive More Opioids for Pain 11/19
Presence or Thoughts of Loved Ones Relieve Pain 11/15
AMA Agrees Marijuana May Have Analgesic Benefits 11/13
American Pain Foundation Absorbs National Pain Foundation 11/12
How Much Relief from Chronic Pain is “Enough”? 11/8
Biofield Therapies for Pain: Help or Hype? 11/7
Mayday Panel Report Urges Revolution in Pain Care 11/6
AAPMedicine Offers Plan for Better Pain Care 11/1
Tough Times Amplify Aches & Pains, APF Survey 11/1
November2009 — Pain Product Announcements & Warnings 11/1
Unapproved codeine sulfate tablet warning, fentanyl buccal film (Onsolis) now available, colchicine (Colcrys) for gout, certolizumab pegol (Cimzia) approved for RA.
<Back to Top>
October 2009
FDA Delays Opioid REMS; Will Industry Snooze? 10/24
Why Primary Care Providers Shun Opioid Therapy 10/23
Chile Peppers Aid Neuropathic Pain – Somewhat 10/22
Magnets, Copper Bracelets Useless for Pain Relief 10/18
FDA Clarifies How to Dispose of Opioids 10/17
Study Finds Analgesic Placebo Effects in Spine 10/16
Placebo Power in Pediatric Gastrointestinal Pain 10/7
U.S. Seniors Want OTC Acetaminophen Saved, Survey 10/6
The DEA & Opioid REMS – An Intimidating Future? 10/4
Drug Combo Helps Relieve Neuropathic Pain 10/3
Alcohol Misuse for Pain, a Commonplace Hazard 10/2
<Back to Top>
September 2009
New Opioid, Exalgo, on Slippery Slope of REMS 9/26
Why Size DOES Matter in Pain Research Trials 9/25
Ultra-High Opioids: When “Too Much” is Just Right 9/22
Can Pain Research Be Trusted? Caveat Lector! 9/19
Yoga Relieves Low Back Pain, But Use Caution 9/17
Pain-Reliever Abuse/Addiction Stabilized in U.S. 9/16
Probability Blindness & Fallacies of FDA REMS 9/12
Dismal Portrait of Chronic Pain Relief; Survey 9/11
Tension Myositis Syndrome & Chronic Pain Myths 9/4
Secrets of Acupuncture for Pain Revealed – a Bit 9/2
<Back to Top>
August 2009
August ‘09 – Pain Product Announcements & Warnings 8/28
Generic sumatriptan succinate, milnacipran (Savella), topical ibuprofen warning, tumor necrosis factor (TNF) blocker warning, extended-release morphine and naltrexone HCl (EMBEDA).
UDT Study Misinterprets Opioid Analgesic Misuse 8/27
Migraine Headache a Risk Factor for CRPS/RSD 8/22
10+ Years on Opioid Analgesics! What Happens? 8/20
“Pain Awareness Month 2009” Sadly Overlooked 8/19
Real or Fake Vertebroplasty Surgery Both Help – Now What? 8/15
EMBEDA, New Opioid Approved with “Interim REMS” 8/14
Rx-Opioid Misuse by Students – REMS Won’t Help 8/12
Methadone Arrhythmia – Debate Rages On 8/8
Surgery Relieves Migraines But Limitations Noted 8/7
Misleading Report Says Antidepressant Use Doubled 8/5
Cigarette Smoking Can Trigger Painful Migraine 8/4
Opioid Deaths – the Enemy is Us? 8/2
Do Vitamin D Deficits Engender More Pain in Women? 8/1
<Back to Top>
July 2009
Depression is Often Behind Medically Unexplained Pain 7/30
Analgesic Medication Guides – A Public Health Failure 7/25
July '09 - Pain Product Announcements & Warnings 7/24
Acetaminophen drops, almotriptan malate (Axert), Bryan Cervical Disc device, diclofenac potassium (Zipsor), diclofenac + potassium bicarbonate (Cambia), fentanyl buccal (Onsolis), golimumab (Simponi), ibuprofen injectable (Caldolor), sumatriptan injection (Sumavel DosePro), tapentadol (Nycynta).
Dosing Ratios for Morphine-to-Methadone Rotation 7/22
“Chilling Effects” of FDA “Black Box” Warnings 7/20
Who is Most Likely to Have Depression with Pain? 7/19
FDA REMS for Onsolis (Fentanyl) Adds Pain to Pain Relief 7/17
Swearing — An Under-Appreciated “Analgesic”? 7/14
FDA Right In Not Banning Propoxyphene Analgesics 7/12
Acetaminophen Debacle; Much Ado About Very Little 7/8
<Back to Top>
March-May 2009; Issue 20
 Download PDF of this document: <Click Here> (318 KB, 19 pp)
Most Therapies for Low Back Pain Offer Little Pain Relief
Acupuncture – Real or Fake – Tops Usual Care for Back Pain
Elastic Lumbar Belt Eases Lower Back Pain
Guideline for Low Back Pain Interventions, Surgery, & Rehab
Arthritis Stems Activity in Adults With Heart Disease
Low-Dose Naltrexone Eases Pain, Fatigue of Fibromyalgia
Patients Hide Use of Complementary & Alternative Medicine
Tips for Preventing Methadone Analgesia Overdose
Trial Supports CR-Oxycodone for Herpes Zoster Pain
Briefly Noted...
> Opioids Favored for Pain in Elderly
> Topical NSAIDs for Osteoarthritis Reviewed
> Three Treatments for Knee Osteoarthritis Found Ineffective
> Vitamin D Reports in Recent Journals
> Fears Prevent Patients From Controlling RA Pain
> Adding Naloxone to Buprenorphine Fails to Deter Injection
Recent Drug or Device Approvals, Announcements, & Warnings
OTC pain relievers; Synvisc-One™ (sodium hyaluronate) injection; Avinza® (morphine sulfate); generic oxycodone; Ryzolt™ (tramadol ER); generic topiramate; antiepileptic drugs; botulinum toxin types A and B; Raptiva® (efalizumab).
<Back to Top>
Lower Back Pain May Have Mixed Origins
Routine Scans For Low Back Pain Don’t Improve Outcomes
Chronic Lower Back Pain Increasing, Survey Shows
Antidepressants for Fibromyalgia Analyzed
Flexible-Dose Pregabalin Effective For Postherpetic Neuralgia
Migraines, Tension Headaches Respond to Acupuncture
Guidelines For Chronic Opioids in Noncancer Pain Published
Briefly Noted...
> Study Challenges High Prevalence of Opioid-Tolerance
> Update on Nonmedical Use of Rx Opioid Analgesics
> FDA Requiring Drug Makers to Have Opioid Safety Plans
> Chronic Pancreatitis Pain Relieved by Antioxidants
> Fibromyalgia Impairs Memory; Do Opioids Help?
> Duloxetine for Osteoarthritis Knee Pain Studied
> Diclofenac Epolamine Patch Relieves Osteoarthritis Pain
> Survey on Complementary Medicine Use For Pain
Recent Drug or Device Approvals, Announcements, & Warnings
Generic analgesic recall, milnacipran HCl (Savella), tocilizumab (RoActemra), oxycodone/naloxone (Targin)
<Back to Top>
 You will need Acrobat® Reader to view PDF files. If you do not have Acrobat Reader, download it free by clicking the icon and following the directions.
| Disclaimer |
| Opinions or viewpoints are those of the source cited as author or "posted by" contributor, unless otherwise specified. News and research items have been edited for length and/or modified for clarity without altering essential data as originally published. Pain Treatment Topics and its advisors and associates do not endorse any medications, products, services, or treatments described, mentioned, or discussed in any of the Updates entries. Nor are any representations made concerning efficacy, appropriateness, or suitability of any such medications, products, services, or treatments.
In view of the possibility of human error or advances in medical knowledge, Pain Treatment Topics and its advisors and associates do not warrant the information contained in News/Research Updates is in every respect accurate or complete, and they are not responsible nor liable for any errors or omissions made by the original sources or for results obtained from the use of this information. If there are questions or needs for further information, readers are advised to consult the reference sources cited or competent medical authorities. |
|
